Eleven countries to breach EU deficit rules Date Sunday, April 28, 2024 - 10:00 PM Description Poland and others push to be exempt from ‘excessive deficit procedure’ owing to their high defence spending
Eleven EU countries push for conclusion of Mercosur trade deal Date Thursday, September 05, 2024 - 11:00 PM Description Also in this newsletter: Brussels changes tack on Italy’s beach bonanza.
Elgar: The Dream of Gerontius — Paul McCreesh combines Anglican chant with Wagnerian opera Date Wednesday, April 17, 2024 - 10:00 AM Description The conductor leads the Gabrieli Consort and Players in this wide-ranging score
Elhedery grasps the HSBC nettle Date Friday, January 31, 2025 - 11:00 AM Description The bank’s retreat in parts of investment banking marks a change after a long journey in the business
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn Date Friday, January 10, 2025 - 11:26 AM Description Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers
Eli Lilly launches cheaper vial version of blockbuster weight-loss drug Date Tuesday, August 27, 2024 - 9:01 AM Description US group races to overcome production bottleneck to meet demand for anti-obesity medicine Zepbound
Eli Lilly lifts guidance on strong sales of diabetes and weight loss drugs Date Tuesday, April 30, 2024 - 10:45 AM Description Shares of world’s most valuable pharmaceuticals group reapproach record highs
Eli Lilly predicts sales jump from obesity drug demand Image Date Tuesday, February 06, 2024 - 6:28 AM Description Drugmaker forecasts higher than expected annual revenue due to soaring demand for weight-loss medication
Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drug Image Date Monday, March 04, 2024 - 10:00 PM Description US group hunts for outsourcers to lift production of Zepbound as it takes on Danish group’s Wegovy blockbuster
Eli Lilly raises outlook on bumper sales of diabetes and weight loss drugs Date Thursday, August 08, 2024 - 7:54 AM Description Shares soar as ‘strong performance’ of Mounjaro and Zepbound medicines underpin jump in revenue